Trial Profile
A Phase II open-label pilot study to assess the effects of Testosterone Metered Dose Transdermal System (MDTS) administration on cognitive function in women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- Sponsors Fempharm
- 23 Jun 2016 New trial record